Wall Street Set To Open Broadly Lower

A surge in coronavirus spread is likely to attract attention, especially when the Pharma company Moderna plans to submit its vaccine for FDA review. The company claimed that the studies have found the vaccine candidate to be effective 94.1 percent at preventing the COVID-19. Pfizer had applied for a review of its COVID -19 vaccine on November 20.